Head of Drug Safety and Pharmacovigilance
Sarah has been with TranScrip since 2009 and leads the TranScrip Drug Safety team. During this time, she has overseen a number of successful projects ranging from signal detection and SmPC label harmonisation to drug safety narratives review. In addition she has assumed the role of clinical safety lead for several successful oncology indication expansion programs involving many interactions with regulatory agencies. Sarah has over 20 years’ experience in the pharma industry before joining TranScrip. More recent previous roles include EU QPPV and Head of Drug Safety (UK Affiliate) for Roche Products Ltd. She also held various senior positions within SmithKline Beecham and ConvaTec.